VA

VR Adviser Portfolio holdings

AUM $1.33B
This Quarter Return
+31.72%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$511M
AUM Growth
+$511M
Cap. Flow
+$15.6M
Cap. Flow %
3.05%
Top 10 Hldgs %
80.15%
Holding
29
New
13
Increased
1
Reduced
1
Closed
7

Top Buys

1
ATHA icon
Athira Pharma
ATHA
$28.1M
2
CRDF icon
Cardiff Oncology
CRDF
$18M
3
IMV
IMV Inc. Common Shares
IMV
$17.8M
4
CLDX icon
Celldex Therapeutics
CLDX
$11.9M
5
MTCR
Metacrine, Inc. Common Stock
MTCR
$11.7M

Top Sells

1
MRNS
Marinus Pharmaceuticals, Inc
MRNS
$58.3M
2
VXRT
Vaxart
VXRT
$24.5M
3
MYOV
Myovant Sciences Ltd.
MYOV
$17.4M
4
NARI
Inari Medical, Inc. Common Stock
NARI
$11.4M
5
AVDL
Avadel Pharmaceuticals
AVDL
$8.55M

Sector Composition

1 Healthcare 72.12%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TRIL
1
DELISTED
Trillium Therapeutics Inc.
TRIL
$102M 20.03% 7,204,577 +414,577 +6% +$5.89M
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$81.4M 15.92% 4,016,873 – –
ALT icon
3
Altimmune
ALT
$338M
$59.4M 11.62% 4,500,000 – –
ATHA icon
4
Athira Pharma
ATHA
$15.3M
$28.1M 5.5% +1,521,623 New +$28.1M
SURF
5
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$26.8M 5.23% 3,877,895 – –
KROS icon
6
Keros Therapeutics
KROS
$618M
$25.9M 5.07% 672,306 – –
RLMD icon
7
Relmada Therapeutics
RLMD
$37.2M
$25.1M 4.92% 668,440 – –
CRDF icon
8
Cardiff Oncology
CRDF
$140M
$18M 3.53% +1,271,985 New +$18M
IMV
9
DELISTED
IMV Inc. Common Shares
IMV
$17.8M 3.47% +4,000,000 New +$17.8M
KURA icon
10
Kura Oncology
KURA
$686M
$17.6M 3.45% 575,000 – –
MRNS
11
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$15.3M 3% 1,192,883 -4,533,657 -79% -$58.3M
CLDX icon
12
Celldex Therapeutics
CLDX
$1.47B
$11.9M 2.32% +800,000 New +$11.9M
MTCR
13
DELISTED
Metacrine, Inc. Common Stock
MTCR
$11.7M 2.28% +1,143,673 New +$11.7M
ALXO icon
14
ALX Oncology
ALXO
$62.7M
$11.3M 2.21% +300,000 New +$11.3M
COGT icon
15
Cogent Biosciences
COGT
$1.69B
$10.2M 1.99% +4,355,273 New +$10.2M
SNDX icon
16
Syndax Pharmaceuticals
SNDX
$1.41B
$9.24M 1.81% 625,710 – –
FSDC
17
DELISTED
FS Development Corp. Class A Common Stock
FSDC
$5.6M 1.1% +500,000 New +$5.6M
TNGX icon
18
Tango Therapeutics
TNGX
$747M
$5.18M 1.01% +500,000 New +$5.18M
TSHA icon
19
Taysha Gene Therapies
TSHA
$797M
$2.6M 0.51% +107,982 New +$2.6M
GRTX
20
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$467K 0.09% +51,653 New +$467K
MDNA
21
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$383K 0.07% +92,453 New +$383K
AVDL
22
Avadel Pharmaceuticals
AVDL
$1.43B
– – -1,057,827 Closed -$8.55M
ETNB icon
23
89bio
ETNB
$1.34B
– – -291,140 Closed -$5.8M
VXRT
24
DELISTED
Vaxart
VXRT
– – -2,765,000 Closed -$24.5M
NARI
25
DELISTED
Inari Medical, Inc. Common Stock
NARI
– – -235,000 Closed -$11.4M
1
2